Morus alba: Clinical Trials

7 trials of Morus alba, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 1 recruiting. 4 Not applicable, 1 Phase 1, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable4Completed 4
Phase 11Recruiting 1
Phase 21Completed 1
Phase 31Completed 1

Follow Morus alba: new trials by email Literature Review of Morus alba trials Research Report on Morus alba

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety of Mulberry Leaf Extract Capsule on Blood Glucose Control in Healthy Volunteer
Mulberry Leaf Extract, Placebo - Healthy Volunteers, Non Diabetic Hyperglycemia
Phase 1RecruitingChulalongkorn University482025-10-012026-04-23
White Mulberry Leaf Extract for Metabolic Health in Overweight Adults Taking Metformin
Mulberry Leaf Extract, Placebo - Weight Management
Not applicableCompletedAzienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo502023-03-012026-05-27
Effect of Mulberry Leaf Extract on Glucose Response of a Test Meal
Mulberry leaf extract, Water - Post-prandial Glycemia
Not applicableCompletedSociété des Produits Nestlé (SPN)242020-01-242023-10-06
Exploratory Study of Efficacy on Selected Natural Extracts Reducing Post Prandial Blood Glucose Response
Mulberry fruit, Mulberry leaf, White bean - Blood Glucose
Not applicableCompletedUnilever R&D722011-11-242020-02-06
Effect of Mulberry Leaf Extract on Blood Glucose
Mulberry leaf extract, Placebo - Prediabetic State
Not applicableCompletedEwha Womans University402011-01-012011-10-28
Observational Study for Subjects With Pompe Disease Undergoing Immune Modulation Therapies
Rituximab, Miglustat - Pompe Disease
CompletedUniversity of Florida112008-10-012017-12-08
Impact of Mulberry Leaf on Type 2 Diabetes
Mulberry Leaf Extract, Placebo - Type 2 Diabetes
Phase 2 / Phase 3CompletedUniversity of Mississippi Medical Center242008-04-012012-08-09

Conditions studied

Diabetes Mellitus, Type 2 (1)  ·  Glycogen Storage Disease Type II (1)  ·  Prediabetic State (1)

Sponsors

Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo (1)  ·  Chulalongkorn University (1)  ·  Ewha Womans University (1)  ·  Société des Produits Nestlé (SPN) (1)  ·  Unilever R&D (1)  ·  University of Florida (1)  ·  University of Mississippi Medical Center (1)

Countries

United States (2)  ·  India (1)  ·  Italy (1)  ·  South Korea (1)  ·  Switzerland (1)  ·  Thailand (1)

Top investigators

Barry J Byrne, MD, PhD (1)  ·  Daniel M Riche, Pharm.D. (1)  ·  David Mela, Dr. (1)  ·  Moon Jong Kim, MD (1)  ·  Oran Kwon, Ph.D (1)  ·  Seok Won Park, MD (1)  ·  Sung Won Kwon, MD (1)

Results publications

PMID 23601496, PMID 28619294, PMID 32647531